US Patent No: 6,884,407

Number of patents in Portfolio can not be more than 2000

Methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator

1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

Improved methods for providing an image of an internal region of a patient, especially the cardiovascular region. Embodiments of the invention involve the administration to the patient of a contrast agent which comprises a vesicle composition comprising lipid or polymer vesicles and a gas or gaseous precursor, in combination with a coronary vasodilator. The patient is scanned using diagnostic imaging, such as ultrasound, to obtain a visible image of the region. The methods are particularly useful for diagnosing the presence of diseased tissue in the cardiovascular region of a patient, as well as for measuring blood flow in the cardiovascular region of a patient.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
LANTHEUS MEDICAL IMAGING, INC.NEW YORK, NY146

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Unger, Evan C Tucson, AZ 150 5510

Cited Art

Patent Info (Count) # Cites Year
 
GE HEALTHCARE AS (22)
4,844,882 Concentrated stabilized microbubble-type ultrasonic imaging agent 213 1987
5,409,688 Gaseous ultrasound contrast media 164 1992
5,558,855 Phase shift colloids as ultrasound contrast agents 97 1993
5,393,524 Methods for selecting and using gases as ultrasound contrast media 159 1993
5,529,766 Contrast agents 88 1993
5,536,490 Contrast agents 97 1993
5,595,723 Method for preparing storage stable colloids 76 1993
5,558,853 Phase shift colloids as ultrasound contrast agents 136 1994
5,562,893 Gas-filled microspheres with fluorine-containing shells 82 1994
5,558,856 Microbubble-generating contrast agents for ultrasound and magnetic resonance imaging 129 1994
5,573,751 Persistent gaseous bubbles as ultrasound contrast media 74 1994
5,558,854 Ultrasound contrast media comprising perfluoropentane and perfluorohexane gas 99 1995
5,558,094 Methods for using persistent gases as ultrasound contrast media 92 1995
5,614,169 Contrast agents, consisting of galactose particles and an amphilic carboxylic acid 58 1995
5,567,413 Flexible amphiphilic microbubbles for ultrasound 90 1995
5,676,928 Liposomes 78 1995
5,707,606 Phase shift colloids as ultrasound contrast agents 52 1995
5,707,607 Phase shift colloids as ultrasound contrast agents 56 1995
5,976,501 Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion 27 1996
6,331,289 Targeted diagnostic/therapeutic agents having more than one different vectors 51 1997
6,261,537 Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors 83 1997
6,159,445 Light imaging contrast agents 134 1997
 
LANTHEUS MEDICAL IMAGING, INC. (18)
5,088,499 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 181 1990
5,205,290 Low density microspheres and their use as contrast agents for computed tomography 116 1991
5,228,446 Gas filled liposomes and their use as ultrasonic contrast agents 89 1991
5,123,414 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 151 1991
5,230,882 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 89 1992
5,352,435 Ionophore containing liposomes for ultrasound imaging 116 1992
5,281,408 Low density microspheres and their use as contrast agents for computed tomography 136 1993
5,305,757 Gas filled liposomes and their use as ultrasonic contrast agents 93 1993
5,469,854 Methods of preparing gas-filled liposomes 165 1993
5,334,381 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 169 1993
5,456,900 Low density microspheres and their use as contrast agents for computed tomography 65 1993
5,542,935 Therapeutic delivery systems related applications 244 1993
5,585,112 Method of preparing gas and gaseous precursor-filled microspheres 170 1993
5,830,430 Cationic lipids and the use thereof 82 1995
5,547,656 Low density microspheres and their use as contrast agents for computed tomography, and in other applications 126 1995
5,527,521 Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications 85 1995
5,846,517 Methods for diagnostic imaging using a renal contrast agent and a vasodilator 88 1997
6,056,938 Cationic lipids and the use thereof 43 1998
 
MOLECULAR BIOSYSTEMS, INC. (10)
4,957,656 Continuous sonication method for preparing protein encapsulated microbubbles 202 1988
5,107,842 Method of ultrasound imaging of the gastrointestinal tract 92 1991
5,315,997 Method of magnetic resonance imaging using diamagnetic contrast 129 1992
5,716,597 Emulsions as contrast agents and method of use 60 1993
5,552,133 Method of making encapsulated gas microspheres useful as an ultrasonic imaging agent 116 1994
5,536,489 Emulsions as contrast agents and method of use 123 1995
5,606,973 Liquid core microdroplets for ultrasound imaging 63 1995
5,732,707 Method of ultrasonically quantitating myocardial perfusion using as intravenously injected tracer 99 1996
5,855,865 Method for making encapsulated gas microspheres from heat denatured protein in the absence of oxygen gas 56 1997
5,965,109 Process for making insoluble gas-filled microspheres containing a liquid hydrophobic barrier 28 1997
 
PFC THERAPEUTICS, LLC (10)
4,865,836 Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport 153 1986
4,919,895 Apparatus for oxygenation of liquid state dissolved oxygen-carrying formulation 79 1987
4,987,154 Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use 131 1987
4,927,623 Dissolution of gas in a fluorocarbon liquid 161 1988
5,080,885 Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport 55 1989
5,077,036 Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid 44 1990
4,993,415 Magnetic resonance imaging with perfluorocarbon hydrides 114 1990
5,393,513 Stable, highly concentrated fluoro carbon emulsions 33 1993
5,344,930 Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties 90 1993
5,679,459 Perfluorinated amphiphilic phosphorous compounds: liposomal compositions 52 1995
 
SCHERING AKTIENGESELLSCHAFT (9)
4,276,885 Ultrasonic image enhancement 270 1979
4,265,251 Method of determining pressure within liquid containing vessel 133 1979
4,442,843 Microbubble precursors and methods for their production and use 210 1981
4,466,442 Carrier liquid solutions for the production of gas microbubbles, preparation thereof, and use thereof as contrast medium for ultrasonic diagnostics 265 1982
4,657,756 Microbubble precursors and apparatus for their production and use 232 1983
4,681,119 Method of production and use of microbubble precursors 197 1986
4,918,065 Corticoid-containing preparation for topical application 51 1988
5,141,738 Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof 165 1991
5,501,863 Contrast media synthesized from polyaldehydes 112 1995
 
BRACCO SUISSE SA (8)
5,271,928 Stable microbubbles suspensions injectable into living organisms 164 1991
5,310,540 Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography 122 1992
5,413,774 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof 132 1992
5,380,519 Stable microbubbles suspensions injectable into living organisms 149 1993
5,445,813 Stable microbubble suspensions as enhancement agents for ultrasound echography 96 1993
5,556,610 Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method 150 1994
5,686,060 Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography 64 1995
6,258,378 Delivery of biologically active substance to target sites in the body of patients 31 1999
 
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (6)
5,567,415 Ultrasound contrast agents and methods for their manufacture and use 83 1994
5,560,364 Suspended ultra-sound induced microbubble cavitation imaging 147 1995
5,701,899 Perfluorobutane ultrasound contrast agent and methods for its manufacture and use 76 1995
5,648,098 Thrombolytic agents and methods of treatment for thrombosis 39 1995
5,849,727 Compositions and methods for altering the biodistribution of biological agents 40 1996
5,740,807 Suspended ultra-sound induced microbubble cavitation imaging 50 1996
 
BRACCO INTERNATIONAL B.V. (6)
4,192,859 Contrast media containing liposomes as carriers 119 1978
5,711,933 Method of making polymeric gas or air filled microballoons for ultrasonic echography 89 1994
5,531,980 Stable microbubbles suspensions injectable into living organisms 93 1994
5,578,292 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof 74 1995
5,567,414 Stable microbubbles suspensions injectable into living organisms 92 1995
5,643,553 Stable microbubbles suspensions injectable into living organisms 94 1995
 
TARGESON, INC. (6)
5,605,673 Stabilized microbubble compositions for ultrasound 95 1994
5,540,909 Harmonic ultrasound imaging with microbubbles 139 1994
5,639,443 Stabilized microbubble compositions 92 1995
5,626,833 Ultrasound imaging method using microbubbles 65 1995
5,804,162 Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients 50 1995
5,733,527 Methods for harmonic imaging with ultrasound 60 1996
 
ABRAXIS BIOSCIENCE, LLC (5)
5,498,421 Composition useful for in vivo delivery of biologics and methods employing same 209 1994
5,508,021 Non-fluorinated polymeric shells for medical imaging 86 1994
5,505,932 Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging 125 1995
5,512,268 Polymeric shells for medical imaging prepared from synthetic polymers, and methods for the use thereof 86 1995
5,639,473 Methods for the preparation of nucleic acids for in vivo delivery 82 1995
 
IMARX THERAPEUTICS, INC. (5)
5,209,720 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes 116 1991
5,358,702 Methoxylated gel particle contrast media for improved diagnostic imaging 75 1993
5,736,121 Stabilized homogenous suspensions as computed tomography contrast agents 28 1995
5,874,062 Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents 34 1995
5,997,898 Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery 22 1995
 
HEMAGEN/PFC (4)
5,514,720 Stable emulsions of highly fluorinated organic compounds 17 1988
5,350,571 Emulsions of highly fluorinated organic compounds 79 1992
5,571,498 Emulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI). 27 1994
5,635,539 Stable emulsions of highly fluorinated organic compounds 20 1996
 
LIPOSOME TECHNOLOGY, INC. (4)
4,737,323 Liposome extrusion method 185 1986
4,781,871 High-concentration liposome processing method 119 1986
4,895,719 Method and apparatus for administering dehydrated liposomes by inhalation 270 1987
5,013,556 Liposomes with enhanced circulation time 453 1989
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (4)
4,921,706 Unilamellar lipid vesicles and method for their formation 114 1984
4,898,734 Polymer composite for controlled release or membrane formation 185 1988
4,893,624 Diffuse focus ultrasound hyperthermia system 116 1988
5,565,215 Biodegradable injectable particles for imaging 95 1994
 
PQ CORPORATION (4)
4,420,442 Manufacturing process for hollow microspheres 106 1982
4,421,562 Manufacturing process for hollow microspheres 93 1983
4,549,892 Process for producing hollow, bilayered silicate microspheres 65 1983
4,540,629 Hollow microspheres with organosilicon-silicate walls 78 1984
 
CEREVAST THERAPEUTICS, INC. (3)
5,149,319 Methods for providing localized therapeutic heat to biological tissues and fluids 174 1990
5,558,092 Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously 279 1995
5,770,222 Therapeutic drug delivery systems 171 1995
 
MINNESOTA MINING AND MANUFACTURING COMPANY (3)
5,785,950 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them 21 1994
5,502,094 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use 59 1995
5,567,765 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use 70 1996
 
NYCOMED IMAGING AS (3)
5,196,183 Contrast agents for ultrasound imaging 111 1991
5,354,549 Iodinated esters 73 1991
5,569,449 Gaseous microparticles as ultrasound contrast agents 85 1995
 
SLF LIMITED PARTNERSHIP (3)
4,572,203 Contact agents for ultrasonic imaging 251 1983
4,718,433 Contrast agents for ultrasonic imaging 238 1985
4,774,958 Ultrasonic imaging agent and method of preparation 227 1987
 
ACUSPHERE, INC. (2)
5,425,366 Ultrasonic contrast agents for color Doppler imaging 220 1993
6,068,857 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production 51 1996
 
AIR PRODUCTS AND CHEMICALS, INC. (2)
4,866,096 Stable fluorochemical aqueous emulsions 67 1987
4,895,876 Concentrated stable fluorochemical aqueous emulsions containing triglycerides 56 1987
 
ALLIANCE PHARMACEUTICAL CORP. (2)
5,460,800 Labeled fluorocarbon compositions 33 1994
5,980,936 Multiple emulsions comprising a hydrophobic continuous phase 21 1997
 
BARNES-JEWISH HOSPITAL (2)
5,958,371 Site specific binding system, nuclear imaging compositions and methods 28 1997
5,989,520 Site specific binding system, imaging compositions and methods 24 1998
 
CALIFORNIA INSTITUTE OF TECHNOLOGY (2)
4,310,505 Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances 120 1979
4,310,506 Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species 133 1980
 
CAVITATION-CONTROL TECHNOLOGY, INC. (2)
4,684,479 Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures 174 1985
5,215,680 Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles 221 1990
 
CHILDREN'S HOSPITAL RESEARCH FOUNDATION (2)
4,775,522 NMR compositions for indirectly detecting a dissolved gas in an animal 113 1985
5,536,753 Stable perfluorocarbon and oil emulsions 15 1990
 
DR. F. KOHLER CHEMIE GMBH (2)
5,137,928 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 142 1991
5,190,982 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 112 1992
 
ELAN PHARMACEUTICALS, INC. (2)
4,981,692 Therapeutic treatment by intramammary infusion 80 1987
5,008,050 Extrusion technique for producing unilamellar vesicles 136 1989
 
EXOGEN, INC. (2)
4,530,360 Method for healing bone fractures with ultrasound 179 1982
5,556,372 Apparatus for ultrasonic bone treatment 104 1995
 
GORDON, DAVID, SKOKIE, ILLINOIS (2)
4,569,836 Cancer treatment by intracellular hyperthermia 89 1983
4,731,239 Method for enhancing NMR imaging; and diagnostic use 118 1986
 
KABUSHIKI KAISHA TOSHIBA (2)
4,620,546 Ultrasound hyperthermia apparatus 134 1985
5,485,839 Method and apparatus for ultrasonic wave medical treatment using computed tomography 103 1994
 
NANOSCAN IMAGING, LLC (2)
5,114,703 Percutaneous lymphography using particulate fluorocarbon emulsions 135 1990
5,496,536 Percutaneous lymphography 36 1995
 
NEXSTAR PHARMACEUTICALS, INC. (2)
4,728,575 Contrast agents for NMR imaging 117 1985
5,008,109 Vesicle stabilization 75 1988
 
NOVAVAX, INC. (2)
5,000,960 Protein coupling to lipid vesicles 97 1989
5,219,538 Gas and oxygen carrying lipid vesicles 83 1991
 
SEQUUS PHARMACEUTICALS, INC. (2)
5,213,804 Solid tumor treatment method and composition 178 1991
5,620,689 Liposomes for treatment of B-cell and T-cell disorders 84 1995
 
SURFACTANT TECHNOLOGIES, INC. (2)
4,426,330 Synthetic phospholipid compounds 128 1981
4,534,899 Synthetic phospholipid compounds 164 1983
 
TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (2)
5,562,608 Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation 162 1995
5,707,352 Pulmonary delivery of therapeutic agent 130 1995
 
UNIVERSITY OF MASSACHUSETTS (2)
4,544,545 Liposomes containing modified cholesterol for organ targeting 354 1983
4,900,540 Lipisomes containing gas for ultrasound detection 179 1983
 
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (2)
5,192,549 Method of amphiphatic drug loading in liposomes by pH gradient 92 1989
5,316,771 Method of amphiphatic drug loading in liposomes by ammonium ion gradient 96 1992
 
AECI LIMITED (1)
4,790,891 Process for the production of a cartridged explosive with entrapped bubbles 81 1987
 
AKTIEBOLAGET DRACO (1)
4,693,999 Liposomes containing steroid esters 59 1985
 
ALKERMES PHARMA IRELAND LIMITED (1)
5,569,448 Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions 127 1995
 
ALZA CORPORATION (1)
4,344,929 Method of delivering drug with aid of effervescent activity generated in environment of use 105 1981
 
AMERICAN BIOSCIENCE, INC. (1)
5,362,478 Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell 132 1993
 
AMERSHAM HEALTH AS (1)
5,897,851 Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging 27 1996
 
ATTA (1)
4,985,550 Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants 85 1987
 
BATTELLE MEMORIAL INSTITUTE (1)
4,224,179 Process for the preparation of liposomes in aqueous solution 234 1978
 
BAYER PHARMA AKTIENGESELLSCHAFT (1)
5,410,516 Ultrasonic processes and circuits for performing them 199 1993
 
BERSTEIN, ROBERT L. (1)
4,663,161 Liposome methods and compositions 101 1985
 
BIOCOMPATIBLES UK LIMITED (1)
4,675,310 Liposome composition as gas transport agents 85 1985
 
CALFEE HALTER & GRISWOLD, LLP (1)
4,603,044 Hepatocyte Directed Vesicle delivery system 119 1984
 
CARLTON MEDICAL PRODUCTS LIMITED (1)
4,646,756 Ultra sound hyperthermia device 122 1983
 
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (1)
4,938,947 Aerosol composition for in vivo imaging 82 1988
 
CIBA CORNING DIAGNOSTICS CORP. (1)
4,933,121 Process for forming liposomes 76 1988
 
COLLABORATIVE RESEARCH, INC. (1)
4,342,826 Immunoassay products and methods 107 1981
 
DANA-FARBER CANCER INSTITUTE, INC. (1)
5,571,797 Method of inducing gene expression by ionizing radiation 49 1994
 
DIOR PARFUMS CHRISTIAN, A COMPANY OF FRANCE (1)
4,621,023 Method of homogenizing dispersions of hydrated lipidic lamellar phases and suspensions obtained by the said method 45 1983
 
DREWES, WILLIAM (1)
4,315,514 Method and apparatus for selective cell destruction 171 1980
 
E. R. SQUIBB & SONS, INC. (1)
4,830,858 Spray-drying method for preparing liposomes and products produced thereby 131 1985
 
EASTMAN KODAK COMPANY (1)
5,078,994 Microgel drug delivery system 93 1990
 
ELI LILLY AND COMPANY (1)
4,331,654 Magnetically-localizable, biodegradable lipid microspheres 221 1980
 
HAFSTRUND NYCOMED INNOVATION, AB (1)
4,984,573 Method of electron spin resonance enhanced magnetic resonance imaging 68 1988
 
HEMAGEN/PFC A LIMITED PARTNERSHIP OF CALIFORNIA (1)
5,403,575 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them 24 1991
 
HEMAGEN/PFC, 655 MONTGOMERY STREET, SUITE 1710, SAN FRANCISCO, CA. 94111, A LIMITED PARTNERSHIP OF CA. (1)
5,171,755 Emulsions of highly fluorinated organic compounds 113 1988
 
HOECHST AKTIENGESELLSCHAFT (1)
5,205,287 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 182 1992
 
ILLINOIS INSTITUTE OF TECHNOLOGY, A NOT-FOR-PROFIT CORP. OF ILLINOIS (1)
4,776,991 Scaled-up production of liposome-encapsulated hemoglobin 118 1986
 
IMCOR PHARMACEUTICAL CO. (1)
5,496,535 Fluorocarbon contrast media for use with MRI and radiographic imaging 73 1991
 
INSIGHTEC LTD. (1)
5,247,935 Magnetic resonance guided focussed ultrasound surgery 111 1992
 
L'OREAL (1)
5,593,680 New cosmetic or dermopharmaceutical compositions in the form of aqueous gels modified by the addition of expanded microspheres 68 1994
 
LA JOLLA CANCER RESEARCH FOUNDATION (1)
5,672,585 Method and composition for treating thrombosis 53 1995
 
LANCASTER GROUP GMBH (1)
5,686,102 Pharmacological composition for topical administration 75 1996
 
LINTON MEDICAL SERVICES LIMITED (1)
4,428,924 Preparation for diagnostic radiology 65 1980
 
LIPOSOME COMPANY, INC., THE (1)
4,229,360 Process for the dehydration of a colloidal dispersion of lipsomes 186 1978
 
LIPSOME TECHNOLOGY, INC. (1)
5,194,266 Amphotericin B/cholesterol sulfate composition and method 73 1991
 
LVMH RECHERCHE, A FRENCH CORP. (1)
5,198,225 Hydrated lipidic lamellar phases or liposomes based on ecdysteroids 79 1991
 
M.R.I., INC. (1)
4,834,964 Use of charged nitroxides as NMR image enhancing agents for CSF 78 1986
 
MALLINCKRODT MEDICAL, INC. (1)
5,362,477 19F magnetic resonance imaging agents which include a nitroxide moiety 48 1992
 
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT (1)
5,612,318 Control of gene expression by ionizing radiation 45 1994
 
NATIONAL RESEARCH DEVELOPMENT CORPORATION (1)
4,427,649 Pharmaceutical compositions 87 1981
 
NIPPON STEEL CORPORATION (1)
5,147,631 Porous inorganic ultrasound contrast agents 185 1991
 
NORTHWESTERN UNIVERSITY (1)
5,612,057 Acoustically reflective liposomes and methods to make and use same 50 1995
 
OLSON, CAMILLA (1)
5,433,204 Method of assessing placentation 134 1993
 
PATRINOVE (1)
5,194,188 Process and a device for the direct production of liposomes 16 1991
 
PHARES PHARMACEUTICAL RESEARCH N.V. (1)
5,004,611 Pro-liposome compositions 83 1988
 
PNC BANK, NATIONAL ASSOCIATION (1)
4,533,254 Apparatus for forming emulsions 245 1984
 
RAIZOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (1)
5,135,000 Method of measuring regional tissue blood flow 97 1991
 
REINHARD SCHLIEF (1)
5,380,411 Ultrasound or shock wave work process and preparation for carrying out same 109 1990
 
RESEARCH DEVELOPMENT FOUNDATION (1)
5,049,388 Small particle aerosol liposome and liposome-drug combinations for medical use 163 1989
 
SCHLIEF, REINHARD (1)
5,195,520 Ultrasonic manometry process in a fluid by means of microbubbles 171 1991
 
SENO MEDICAL INSTRUMENTS, INC. (1)
5,840,023 Optoacoustic imaging for medical diagnosis 156 1996
 
STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (1)
4,863,717 Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging 122 1986
 
SUMMERS, DAVID (1)
5,186,922 Use of biodegradable microspheres labeled with imaging energy constrast materials 114 1990
 
SYNTEX (U.S.A.) INC. (1)
5,470,582 Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles 100 1993
 
TAKEDA CHEMICAL INDUSTRIES, LTD. (1)
4,877,561 Method of producing liposome 86 1987
 
TECHNOMED MEDICAL SYSTEMS (1)
4,658,828 Apparatus for examining and localizing tumors using ultra sounds, comprising a device for localized hyperthermia treatment 142 1985
 
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (1)
5,858,399 Acoustically reflective liposomes and methods to make and use the same 41 1996
 
THE CURATORS OF THE UNIVERSITY OF MISSOURI (1)
4,789,501 Glass microspheres 156 1984
 
THE DOW CHEMICAL COMPANY (1)
4,485,193 Expandable synthetic resinous thermoplastic particles, method for the preparation thereof and the application therefor 43 1984
 
THE LUBRIZOL CORPORATION (1)
4,728,578 Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers 85 1986
 
THE PENN STATE RESEARCH FOUNDATION (1)
5,487,390 Gas-filled polymeric microbubbles for ultrasound imaging 126 1994
 
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1)
4,767,610 Method for detecting abnormal cell masses in animals 37 1984
 
THE REGENTS OF THE UNIVERSITY OF MICHIGAN (1)
4,689,986 Variable frequency gas-bubble-manipulating apparatus and method 119 1985
 
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (1)
5,545,396 Magnetic resonance imaging using hyperpolarized noble gases 123 1994
 
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (1)
5,196,348 Perfluoro-crown ethers in fluorine magnetic resonance spectroscopy of biopsied tissue 55 1991
 
THE UNIVERSITY OF BRITISH COLUMBIA (1)
5,283,255 Wavelength-specific cytotoxic agents 65 1992
 
THOMSON-CSF (1)
4,586,512 Device for localized heating of biological tissues 153 1985
 
TRANSAVE, INC. (1)
5,552,155 Fusogenic lipsomes and methods for making and using same 61 1994
 
TRANSON LLC A DELAWARE CORPORATION (1)
5,695,460 Enhancement of ultrasound thrombolysis 91 1995
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (1)
5,019,370 Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging 99 1989
 
VANDERBILT UNIVERSITY (1)
4,615,879 Particulate NMR contrast agents for gastrointestinal application 133 1983
 
WAYNE STATE UNIVERSITY (1)
5,045,304 Contras agent having an imaging agent coupled to viable granulocytes for use in magnetic resonance imaging of abscess and a method of preparing and using same 71 1988
 
WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINICAL RESEARCH CENTRE LIMITED (1)
5,648,095 Preparation of microparticles 104 1994
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (5)
4,822,534 Method of producing microspheres 93 1987
4,996,041 Method for introducing oxygen-17 into tissue for imaging in a magnetic resonance imaging system 102 1988
5,190,766 Method of controlling drug release by resonant sound wave 154 1991
5,315,998 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same 157 1992
5,339,814 Process for visualizing tissue metabolism using oxygen-17 50 1992

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
UNIVERSITY OF SOUTH FLORIDA (2)
7,981,442 Ultrasound enhancement of drug release across non-ionic surfactant membranes 0 2006
8,435,558 Ultrasound enhancement of drug release across non-ionic surfactant membranes 0 2011
 
BOSTON SCIENTIFIC SCIMED, INC. (1)
7,991,455 Systems and methods for dynamic optical imaging 0 2008
 
KONINKLIJKE PHILIPS ELECTRONICS N.V. (1)
7,625,341 Elevation beamwidth control for contrast imaging 0 2005
 
LANTHEUS MEDICAL IMAGING, INC. (1)
8,084,056 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 0 2003
 
MARVAL BIOSCIENCES, INC. (1)
8,357,351 Nano-scale contrast agents and methods of use 0 2009
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (2)
7,526,331 Enhanced cardiac radionuclide imaging techniques 0 2004
8,298,282 Magnetic resonance-compatible medical implant 0 2004

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 26, 2016
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00